Financial Health Report: Oncolytics Biotech, Inc (ONCY)’s Ratios Tell a Tale

Ulysses Smith

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.02 million shares were traded. ONCY stock price reached its highest trading level at $1.35 during the session, while it also had its lowest trading level at $1.26.

Ratios:

For a better understanding of ONCY, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.88 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.10.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on August 13, 2025, initiated with a Buy rating and assigned the stock a target price of $7.

On October 06, 2022, Maxim Group started tracking the stock assigning a Buy rating and target price of $3. On February 17, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.H.C. Wainwright initiated its Buy rating on February 17, 2021, with a $15 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ONCY now has a Market Capitalization of 132632256 and an Enterprise Value of 117735064.

Stock Price History:

The Beta on a monthly basis for ONCY is 1.19, which has changed by 0.36458337 over the last 52 weeks, in comparison to a change of 0.17089343 over the same period for the S&P500. Over the past 52 weeks, ONCY has reached a high of $1.53, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is 21.53%, while the 200-Day Moving Average is calculated to be 68.51%.

Shares Statistics:

Over the past 3-months, ONCY traded about 1.27M shares per day on average, while over the past 10 days, ONCY traded about 1802110 shares per day. A total of 100.36M shares are outstanding, with a floating share count of 98.09M. Insiders hold about 2.27% of the company’s shares, while institutions hold 9.65% stake in the company. Shares short for ONCY as of 1756425600 were 2330029 with a Short Ratio of 1.96, compared to 1753920000 on 2436840. Therefore, it implies a Short% of Shares Outstanding of 2330029 and a Short% of Float of 2.3800000000000003.

Earnings Estimates

Oncolytics Biotech, Inc (ONCY) is presently subject to a detailed evaluation by 4.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.08.

Analysts are recommending an EPS of between -$0.27 and -$0.3 for the fiscal current year, implying an average EPS of -$0.28. EPS for the following year is -$0.33, with 4.0 analysts recommending between -$0.27 and -$0.39.

Leave a Comment

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.